Home›People›Mohamed Genead
MG

Mohamed Genead

Executive officer and director at Aviceda Therapeutics.

ExecutiveDirector
Updated Oct 27, 2026·Latest SEC filing Jan 13, 2025·Suggest an edit

About Mohamed Genead

Mohamed Genead is an executive officer and director at Aviceda Therapeutics.

Mohamed Genead first appears on SEC filings in 2020.

Experience

This experience comes from SEC filings. The years are when the filings name Mohamed Genead in the role, so the role may have started earlier or lasted longer.

Aviceda Therapeutics, Inc.
Executive officer and director
2020 – 2025 · Cambridge, MA

Key Colleagues at Startups

The people Mohamed Genead works with at each company, as listed on that company's latest Form D.

Aviceda Therapeutics, Inc. · Form D/A, Jan 13, 2025
DC
David Callanan
Executive officer
NT
MT
Michael Tolentino
Executive officer and director
CA
TH
Tarek Hassan
Executive officer
EL
Erin Lavelle
Director
DG
David Guyer
Director
DK
Derek Kunimoto
Member of Office of CEO & President
JW
Jay Woods
Director

Sources

  1. SECAviceda Therapeutics, Inc. Form D/A, filed Jan 13, 2025